News

Myasthenia gravis is a rare neurological autoimmune disease characterized by fluctuating muscle weakness that worsens with activity. About 17,000 people in Germany suffer from the disease. Many struggle to access appropriate care, especially if they need complex immunotherapies. The start-up RareLink now aims to address this gap with its MyaLink…

Dr. med. Livius Penter, internist, and Dr. med. Jana Ihlow, pathologist, are fellows in the Clinician Scientist Program researching how allogeneic stem cell transplants and immunotherapeutic strategies can be used to treat acute myeloid leukaemia (AML). The Brigitte and Dr. Konstanze Wegener Foundation is now funding their joint project beginning…

On April 8, 2025, the kick-off meeting of the first fellows of the nTTP-GCT program took place in Berlin. In an informal atmosphere, the fellows exchanged ideas and were informed about the program components and aims of the National Strategy for GCT. A successful start for the GCT funding of translational talents!

Together with the Biomedical Innovation Academy of the Berlin Institute of Health at Charité (BIH), Stiftung Charité 2024 has developed two new funding programs. The first fellows have now been selected.

Prof. Dr. med. Nathanael Raschzok, Fellow of the BIH Charité Advanced Clinician Scientist Pilot Program and alumnus of the Clinician Scientist Program, and his team at the Department of Surgery, Charité Campus Mitte | Campus Virchow-Klinikum, have received funding from the DFG to conduct a clinical trial aimed at reducing time-to-transplant for…

The new funding line supports tandems of Junior Clinician Scientists and Translational Scientists interested in research with regard to their career, network and competence development in the GCT field.